H19 RNA downregulation stimulated melanogenesis in melasma

A variety of factors, including ultraviolet (UV) exposure, have been implicated in the pathogenesis of melasma. However, UV‐induced hyperpigmentation usually recovers spontaneously, whereas melasma does not. Recently, we detected downregulation of the H19 gene on microarray analysis of hyperpigmented and normally pigmented skin from patients with melasma, and identified significant clinical correlations. The H19 downregulation was not accompanied by a reciprocal change of the imprinted gene, insulin‐like growth factor II. Moreover, methylation pattern of the H19 promoter region in maternal ICR was variable. The H19 knockdown in melanocyte monoculture did not result in obvious tyrosinase overexpression, whereas the knockdown in a mixed cell culture system, composed of H19 siRNA transfected normal human keratinocytes and non‐transfected normal human melanocytes, did induce not only a tyrosinase overexpression but also an increase of melanosome transfer. Estrogen treatment of the H19 RNA knockdown in the mixed cell culture was more than an additive effect on the tyrosinase overexpression, whereas UV irradiation was not. These findings suggest that downregulation of H19 and a sufficient dose of estrogen might be involved in the development of melasma.

[1]  B. Cullen,et al.  The imprinted H19 noncoding RNA is a primary microRNA precursor. , 2007, RNA.

[2]  N. Jenkins,et al.  Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein , 1993, Cell.

[3]  M. Bartolomei,et al.  Establishment and maintenance of H19 imprinting in the germline and preimplantation embryo , 2006, Cytogenetic and Genome Research.

[4]  C. Chao,et al.  A method for quantifying melanosome transfer efficacy from melanocytes to keratinocytes in vitro , 2008, Pigment cell & melanoma research.

[5]  A. Hochberg,et al.  Parental imprinting of the human H19 gene , 1992, FEBS letters.

[6]  B. Gilchrest,et al.  MITF mediates cAMP-induced protein kinase C-β expression in human melanocytes , 2006 .

[7]  Victor V Lobanenkov,et al.  Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive , 2000, Current Biology.

[8]  M. Azim Surani,et al.  Parental-origin-specific epigenetic modification of the mouse H19 gene , 1993, Nature.

[9]  S. Sachdeva.  THE DERMATOSES OF PREGNANCY , 2008, Indian journal of dermatology.

[10]  M. Katdare,et al.  Curcumin downregulates H19 gene transcription in tumor cells , 2008, Journal of cellular biochemistry.

[11]  M. Bartolomei,et al.  Physical linkage of two mammalian imprinted genes, H19 and insulin–like growth factor 2 , 1992, Nature genetics.

[12]  D. Fisher,et al.  Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes , 1998, The Journal of cell biology.

[13]  B. Gilchrest,et al.  MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes. , 2006, The Biochemical journal.

[14]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[15]  R. Buscà,et al.  Different cis-Acting Elements Are Involved in the Regulation of TRP1 and TRP2 Promoter Activities by Cyclic AMP: Pivotal Role of M Boxes (GTCATGTGCT) and of Microphthalmia , 1998, Molecular and Cellular Biology.

[16]  Z. Abdel‐Malek,et al.  Mitogen- and ultraviolet-B-induced signaling pathways in normal human melanocytes. , 2002, The Journal of investigative dermatology.

[17]  Sodhi Vk,et al.  Dermatoses of pregnancy. , 1988 .

[18]  M. Khaled,et al.  Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway. , 2003, The Journal of investigative dermatology.

[19]  M. Mihm,et al.  Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. , 1981, Journal of the American Academy of Dermatology.

[20]  S. Sohn,et al.  Melasma: histopathological characteristics in 56 Korean patients , 2002, The British journal of dermatology.

[21]  A. Feinberg,et al.  Loss of imprinting in hepatoblastoma. , 1995, Cancer research.

[22]  A. Gabory,et al.  The H19 gene: regulation and function of a non-coding RNA , 2006, Cytogenetic and Genome Research.

[23]  C. Polychronakos,et al.  Parental genomic imprinting of the human IGF2 gene , 1993, Nature Genetics.

[24]  H. Nagai,et al.  Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. , 2000, The Journal of investigative dermatology.

[25]  B. Tycko,et al.  Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. , 1993, American journal of human genetics.

[26]  T. Ekström,et al.  IGF2 is parentally imprinted during human embryogenesis and in the Beckwith–Wiedemann syndrome , 1993, Nature Genetics.

[27]  J. Clayton-Smith,et al.  Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. , 1996, Human molecular genetics.

[28]  Shirley M. Tilghman,et al.  CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus , 2000, Nature.

[29]  G. B. Petersen,et al.  Methylation Sequencing Analysis Refines the Region ofH19 Epimutation in Wilms Tumor* , 1999, The Journal of Biological Chemistry.

[30]  W. Reik,et al.  Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome. , 1997, Human molecular genetics.

[31]  J. Sutcliffe,et al.  Mouse/human sequence divergence in a region with a paternal-specific methylation imprint at the human H19 locus. , 1996, Human molecular genetics.

[32]  G. Pfeifer,et al.  Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function , 2000, Current Biology.